Provided by Tiger Trade Technology Pte. Ltd.

CLIMB BIO INC

13.73
-0.8400-5.77%
Post-market: 13.860.1300+0.95%17:53 EDT
Volume:1.44M
Turnover:19.92M
Market Cap:786.19M
PE:-16.45
High:14.70
Open:14.58
Low:13.49
Close:14.57
52wk High:18.33
52wk Low:1.54
Shares:57.26M
Float Shares:41.60M
Volume Ratio:1.16
T/O Rate:3.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8347
EPS(LYR):-0.8974
ROE:-27.10%
ROA:-18.45%
PB:3.28
PE(LYR):-15.30

Loading ...

Climb Bio Inc : Leerink Partners Raises Target Price to $15 From $10

THOMSON REUTERS
·
May 06

Climb Bio Initiated at Buy by Chardan Capital

Dow Jones
·
May 06

Climb Bio reports Phase 1 budoprutug subcutaneous data supports patient trials

Reuters
·
May 05

Chardan Initiates Climb Bio at Buy With $22 Price Target

MT Newswires Live
·
May 05

U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, Onsemi

Reuters
·
May 05

Climb Bio Inc : Chardan Capital Markets Initiates Coverage With Buy Rating; Target Price $22

THOMSON REUTERS
·
May 05

Analysts Have Conflicting Sentiments on These Healthcare Companies: Climb Bio (CLYM), ICU Medical (ICUI) and Stryker (SYK)

TIPRANKS
·
May 04

Piper Sandler Remains a Buy on Climb Bio (CLYM)

TIPRANKS
·
May 04

BUZZ-U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, Veradermics

Reuters
·
Apr 28

Climb Bio prices USD 110 million private placement at USD 9.5 per share

Reuters
·
Apr 28

Climb Bio Inc - Private Placement Expected to Close on or About April 29, 2026

THOMSON REUTERS
·
Apr 28

Press Release: Climb Bio, Inc. Announces $110.0 Million Private Placement

Dow Jones
·
Apr 28

Climb Bio announces annual shareholder meeting

Reuters
·
Apr 25

Analysts Offer Insights on Healthcare Companies: Passage Bio (PASG), Climb Bio (CLYM) and Zai Lab (ZLAB)

TIPRANKS
·
Apr 21

U.S. RESEARCH ROUNDUP-CNX Resources, P&G, Prologis

Reuters
·
Apr 21

Climb Bio Inc : Mizuho Initiates Coverage With Outperform Rating; Price Target $18

THOMSON REUTERS
·
Apr 15

Climb Bio announces annual shareholder meeting

Reuters
·
Apr 11

Climb Bio (CLYM) Gets a Buy from Piper Sandler

TIPRANKS
·
Apr 10

Climb Bio hosts R&D Spotlight webcast on budoprutug CD19 program opportunity

Reuters
·
Apr 08

Climb Bio Price Target Maintained With a $8.00/Share by BTIG

Dow Jones
·
Apr 08